Summary
Sham-operated (SO) and paraplegic rats were treated from the day of operation during a period of 4 or 6 weeks with salmon calcitonin 4 IU/kg/day or a diphosphonate (APD) 1mM/kg/day or indomethacin 2.5 mg/kg/day. The consequence of spinal cord section on the femur and tibia is a loss of mineral which affects predominantly trabecular bone (−24 and −13% in calcium content for the tibial metaphysis and the whole bone, respectively, when compared with the SO controls), a twofold increase in bone blood flow as measured by the technique of the microspheres trapping, a moderate decrease of the 72 hour45Ca accretion rate in the bone shaft, and an increase in the number of metaphyseal osteoclasts in the tibia. In paraplegics, all three drugs inhibit bone loss to some degree, calcitonin and indomethacin being mostly effective on the cortical bone of the shaft, and APD tremendously increasing the trabecular network of the metaphysis. APD is the only drug to exhibit a significant effect on the calcium content of the bones of the SO controls, but some effect is apparent for calcitonin on X-rays and histological preparations. The increase in bone blood flow in paraplegics is unaffected, this point being discussed in view of the hypothesis of the resorptive action of prostaglandins produced by newly formed vessels.45Ca accretion rate increases in the shaft of calcitonintreated paraplegics, whereas it decreases in APD-treated controls and paraplegics. The number of osteoclasts decreases in paraplegics treated with calcitonin and indomethacin, and increases in both controls and paraplegics treated with APD. Thus, APD shows an outstanding effect on the bone loss at the very place where it occurs preferentially in the paraplegics (the trabecular metaphysis), but this and other effects affect the controls as well. Calcitonin and indomethacin act almost selectively on the diseased animals. All three drugs fail to inhibit the bone blood flow increase observed in paraplegics and supposedly associated with bone resorption.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Verhas M, Martinello Y, Mone M, Heilporn A, Bergmann P, Tricot A, Schoutens A (1980) Demineralization and pathological physiology of the skeleton in paraplegic rats. Calcif Tissue Int 30:83–90
Braddom RL, Erickson R, Johnson EW (1973) Ineffectiveness of calcitonin on osteoporosis in paraplegic rats. Arch Phys Med Rehab 54:170–174
Naftchi NE, Viau AT, Sell GH, Lowman EW (1980) Spinal cord injury: effect of thyrocalcitonin on calcium, magnesium and phosphorus in paraplegic rats. Arch Phys Med Rehab 61:575–579
Weiss RE, Singer FR, Gorn AH, Hofer DP, Nimni ME (1981) Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. J Clin Invest 68:815–818.
Wase AW, Peterson A, Rickes E, Solewski J (1966) Some effects of thyrocalcitonin on the calcium metabolism of the rat. Endocrinology 79:687–691
Aldred JP, Luna PD, Zeedyk RA, Bastian JW (1976) Inhibition by salmon calcitonin (SCT) of desoxycorticosterone acetate (DOCA)-induced hypertension in the rat (394339). Proc Soc Exp Biol Med 152:557–559.
Staehelin A (1977) Treatment of arterial circulatory disorders with calcitonin. Schweiz Med Wschr 107(49):1865–1867.
Driessens M, Vanhoutte PM (1981) Effect of calcitonin, hydrocortisone, and parathyroid hormone on canine bone blood vessels. Am J Physiol 241 (Heat Circ Physiol 10):H91-H94
Reitsma PH, Bijvoet OLM, Potokar M, van der Wee-Pals LJA, van Wijk-van Lennep MML (1983) Apposition and resorption of bone during oral treatment with (3-Amino-1-Hydroxypro-pylidene)-1,1-Bisphosphonate (APD). Calcif Tissue Int 35:357–361
Chambers TJ (1980) Diphosphontes inhibit bone resorption by macrophages in vitro. J Pathol 132:255–262.
Reitsma PH, Bijvoet OLM, Verlinden-Ooms H, van der Wee-Pals LJA (1980) Kinetic studies of bone and mineral metabolism during treatment with (3-Amino-1-Hydroxypropylidene)-1, 1-Bisphosphonate (APD) in rats. Calcif Tissue Int 32:145–157
Törnkvist H, Bauer FC, Nilsson OS (1985) Influence of indomethacin on experimental bone metabolism in rats. Clin Orthop Rel Res 193:264–271
Johannes RO, Sudmann E, Marton PF (1976) Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 47:588–599
Allen HL, Wase A, Bear WT (1980) Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 51:595–600
Rowe DJF, Gedeon G, Broom J, Fleck A (1979) The effect of indomethacin on the biochemical response to fracture stress in rats. Br J Exp Pathol 60:589–595
Robin JC, Brown MJ, Weinfeld N, Dziak R (1982) Prostacyclin: effects on cyclic AMP in bone cells. Chem Pathol Pharmacol 35:43–49
Conaway HH, Diez LF, Raisz LG (1986) Effects of prostacyclin and prostaglandin E1 (PGE1) on bone resorption in the presence and absence of parathyroid hormone. Calcif Tissue Int 38:130–134
Raisz LG, Vanderhoek JY, Simmons HA, Kream BE, Nicolaou KC (1979) Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin. Prostaglandins 17:905–915
Wolfe HJ, Bitman WR, Voelkel EF, Griffiths HJ, Tashjian AH (1978) Systemic effects of the VX2 carcinoma on the osseous skeleton. Lab Invest 38:208–215
Nefussi JR, Baron Roland (1985) PGE2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum, in fetal rat long bone cultures. Anat Rec (Philadelphia) 211:9–16
Jee WSS, Ueno K, Deng YP, Woodbury DM (1985) The effects of prostaglandin E in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int 37:148–157
Yonaga T, Morimoto S (1979) A calcitonin-like action of prostaglandin E1 Prostaglandins 17:801–819
Dekel S, Lenthall G, Francis MJO (1981) Release of prostaglandins from bone and muscle after tibial fracture. JBJS 63-B:185–189
Schoutens A, Verhas M, L'Hermite-Baleriaux, M, L'Hermite M, Verschaeren A, Dourov N, Mone M, Heilporn A, Tricot A (1984) Growth and bone haemodynamic responses to castration in male rats. Reversibility by testosterone. Acta Endocrinol 107:428–432
Verhas M, Schoutens A, L'Hermite-Baleriaux M, Dourov N, Verschaeren A, Mone M, Heilporn A (1986) The effect of orchidectomy on bone metabolism in aging rats. Calcif Tissue Int 39:74–77
Ohya K, Yamada S, Felix R, Fleisch H (1985) Effect of bisphosphonates on prostaglandin synthesis by rat bone cells and mouse calvaria in culture. Clin Sci 69:403–411
Ceserani R, Colombo M, Olgiati VR, Pecile A (1979) Calcitonin and prostaglandin system. Life Sci 25(21):1851–1856
Williams TJ, Peck MJ (1977) Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270:530–532
Sondergaard J, Greaves MW (1971) Prostaglandin E1: effect on human cutaneous vasculature and skin histamine. Br J Dermatol 84:424–428.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schoutens, A., Verhas, M., Dourov, N. et al. Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin. Calcif Tissue Int 42, 136–143 (1988). https://doi.org/10.1007/BF02556346
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02556346